Memorial Sloan Kettering Cancer Center
@mskcancercenter.bsky.social
📤 4851
📥 255
📝 361
One of the world’s leading comprehensive cancer centers. To make an appointment: 833-637-6698
reposted by
Memorial Sloan Kettering Cancer Center
Aguirre-Ghiso Lab
about 19 hours ago
What a pleasure to have hosted Dr. Joan Massague from MSKCC
@mskcancercenter.bsky.social
who visited us all day and delivered an exceptional lecture for our
@einsteinmededu.bsky.social
Montefiore Einstein Comprehensive Cancer Center distinguished lecture series. Thanks for visiting!
0
6
1
#ICYMI
: 36 MSK researchers are among the
@clarivateag.bsky.social
list of Highly Cited Researchers 2025, which identifies scientists who have demonstrated significant and broad influence in their field(s) of research.
loading . . .
Memorial Sloan Kettering Cancer Center Applauds Highly Cited Researchers 2025
In 2025, MSK was again ranked among the top organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers, published...
https://www.mskcc.org/news/mskcc-applauds-highly-cited-researchers-2025?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+computer+screen&utm_campaign=Social+Media+Posts+November+2025
2 days ago
0
2
0
Experts at MSK are making strides in cancer care. New research uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative
#breastcancer
among Black women; and more.
loading . . .
MSK Research Highlights, October 31, 2025
New MSK research uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative breast cance...
https://www.mskcc.org/news/msk-research-highlights-october-31-2025?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Carousel+graphics&utm_campaign=Social+Media+Posts+November+2025
3 days ago
0
4
1
A team at MSK is shedding new light on
#VEXAS
syndrome, a severe autoinflammatory condition arising from a mutation in the UBA1 gene. “We are hopeful that the therapeutic targets identified by our research can pave the way for new approaches.” says
@gitlinlabmsk.bsky.social
.
bit.ly/4oRQ5LF
8 days ago
0
4
2
reposted by
Memorial Sloan Kettering Cancer Center
VJHemOnc
9 days ago
At
#iwNHL25
, Alexey Danilov of
@cityofhope.bsky.social
and Meghan Thompson of
@mskcancercenter.bsky.social
sat down to provide an update on BTK-targeting therapies in non-Hodgkin
#lymphoma
and CLL.🩸 This is a discussion you don't want to miss! Click here: 🎥
buff.ly/t3TZTiT
#LYMsm
#HemOnc
0
2
1
reposted by
Memorial Sloan Kettering Cancer Center
Alex Gitlin
11 days ago
🚨Thrilled to share our latest work, published online today
@nature.com
in which we decipher mechanisms underlying the enigmatic VEXAS syndrome - a huge team effort
@mskcancercenter.bsky.social
led by superstars Varun Narendra +
@tandriladas.bsky.social
1/
www.nature.com/articles/s41...
loading . . .
Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome - Nature
Nature - Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome
https://www.nature.com/articles/s41586-025-09815-0
3
19
10
Congratulations to this year’s recipients of the MSK 2025 Paul Marks Prize for Cancer Research: Dr.
@oawlab.bsky.social
, of MSK; Dr. Andrea Ablasser, of EPFL; and Dr. Christina Curtis, of
@stanfordmedicine.bsky.social
. Learn more about the winners:
bit.ly/47y8HLb
10 days ago
0
5
3
reposted by
Memorial Sloan Kettering Cancer Center
eric lai
15 days ago
thanks to
@mskcancercenter.bsky.social
for sponsoring the SKI Basic Science Retreat, highlighting fundamental discoveries and forging new interactions amongst colleagues. our lab presented the next three papers we are writing up, ranging from miRNA biology, neural RBPs, to Hox TF grammar! 🔬🪰🧬
1
11
1
reposted by
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
17 days ago
Eugene Pietzak, MD, of
Memorial Sloan Kettering Cancer Center
leads Alliance A032303/GAIN-BCG testing if the addition of the anti-cancer drug gemcitabine to the standard treatment of BCG immunotherapy helps patients whose bladder cancer has recurred. Learn more at
https://bit.ly/Alliance-A032303
.
0
1
1
Here, Dr. Pedram Razavi explains MSK's efforts to prevent drug resistance from developing in
#breastcancer
patients. A new study seeks to anticipate the malignant cells' next move, like playing poker with cancer and being able to see most of its cards. Learn more:
bit.ly/47cxyDZ
17 days ago
0
2
2
reposted by
Memorial Sloan Kettering Cancer Center
Abdel-Wahab Lab, MSKCC
22 days ago
Excited to announce a new publication from our
@mskcancercenter.bsky.social
Histiocytosis group identifying a predictor for impaired response to MEK inhibition in histiocytosis patients and potential for ERK inhibition. Out today in @Cancer_Cell.
www.sciencedirect.com/science/arti...
loading . . .
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition
Histiocytic neoplasms are clonal disorders of the monocyte/macrophage lineage defined by mutations activating mitogen-activated protein kinase (MAPK) …
https://www.sciencedirect.com/science/article/pii/S1535610825004064
1
9
4
MSK experts are investigating whether
#brachytherapy
may be an effective treatment option for reducing local recurrence, lowering the risk of
#necrosis
associated with standard
#radiation
, and improving the quality of life for patients with brain
#metastases
. Learn more ⬇️
loading . . .
Brachytherapy for Brain Metastases
As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease.
https://www.mskcc.org/clinical-updates/brachytherapy-for-brain-metastases?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+doctor&utm_campaign=Social+Media+Posts+October+2025
22 days ago
0
3
1
We're excited to share that we've been recognized as #1 in oncology on
@newsweek.com
's World's Best Specialized Hospitals List.
bit.ly/4nefIFv
23 days ago
0
5
3
reposted by
Memorial Sloan Kettering Cancer Center
MSK Department of Medicine
24 days ago
#ESMO25
may be over, but
#cancerresearch
continues! Dr. Vicky Makker presented 5-year follow-up data from the 309/KEYNOTE-775 study that confirmed the efficacy and safety of lenvatinib plus pembrolizumab in advanced
#endometrialcancer
.
@mskcancercenter.bsky.social
➡️
bit.ly/3JncnWA
0
3
2
We're excited to share that Dr. Omar Abdel-Wahab, a leukemia specialist at MSK, has been elected to the
@nam.edu
. With Dr. Abdel-Wahab’s appointment, a total of 28 MSK faculty members have been conferred with this recognition. Congratulations, Dr. Abdel-Wahab!
bit.ly/49ezKw0
loading . . .
Memorial Sloan Kettering Cancer Center Physician-Scientist Elected to the Prestigious National Academy of Medicine
Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Me...
https://bit.ly/49ezKw0
24 days ago
2
30
9
MSK researchers presented exciting advances in medical oncology for a range of cancer types at the
@myesmo.bsky.social
Congress 2025 held in Berlin. Highlights include the latest updates on phase 1 trials testing innovative treatment approaches for select patients w/ advanced solid tumors and more:
loading . . .
ESMO 2025 Research Roundup: MSK Presents Exciting Advances in Medical Oncology Research
MSK researchers presented exciting advances in medical oncology for a range of cancer types at the ESMO Congress 2025. Highlights included the latest updates on three phase 1 trials testing innovative...
https://www.mskcc.org/clinical-updates/esmo-2025-research-roundup-msk-presents-exciting-advances-in-medical-oncology-research?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+lab&utm_campaign=Social+Media+Posts+October+2025
25 days ago
0
3
3
reposted by
Memorial Sloan Kettering Cancer Center
MSK Department of Medicine
28 days ago
Tomorrow at
#ESMO25
, Violaine Randrian will present a study investigating whether the mechanism of mismatch repair protein loss impacts outcomes for those with solid tumors treated with
#immunotherapy
.
@mskcancercenter.bsky.social
Learn more:
bit.ly/4neLsu1
🗓️ October 18 | 11:10 a.m. CEST
0
1
1
reposted by
Memorial Sloan Kettering Cancer Center
MSK Department of Medicine
28 days ago
Don't miss the first presidential symposium at
#ESMO25
! Tomorrow, join @DrRosenbergMSK to hear his thoughts on a study of perioperative enfortumab vedotin plus pembrolizumab in participants with muscle-invasive
#bladdercancer
.
@mskcancercenter.bsky.social
Learn more:
bit.ly/42JM3ws
0
3
2
reposted by
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Continuing Medical Education
28 days ago
Join us on November 12 (8:30–10:30 am) for new a complimentary series exploring how imagination, spirituality, and artistic expression serve as powerful resources in cancer care, featuring Will Schwalbe and Chef JJ Johnson:
bit.ly/CreativeHeart2025
@mskcancercenter.bsky.social
#MSKCreativeHeartCME
0
3
2
reposted by
Memorial Sloan Kettering Cancer Center
MSK Department of Medicine
28 days ago
Tomorrow at
#ESMO25
, Dr. Vicky Makker will present at an education session about selecting the best first-line treatment based on molecular classification.
@mskcancercenter.bsky.social
@myesmo.bsky.social
Learn more:
bit.ly/3W6rqqz
0
2
3
reposted by
Memorial Sloan Kettering Cancer Center
The Mark Foundation for Cancer Research
29 days ago
Huge congratulations to
@rosslevinemd.bsky.social
, who has been named
@mskcancercenter.bsky.social
's new Chief Scientific Officer! We’re deeply grateful to have his expertise on our Board of Directors and as Chair of our Scientific Advisory Committee.
www.mskcc.org/news-release...
0
3
1
Exciting news: Dr. Ross Levine, Senior Vice President of Translational Research at MSK, has been named MSK's new Chief Scientific Officer (CSO). Congratulations, Dr. Levine!
bit.ly/4hfeWq7
29 days ago
0
17
2
When a routine prenatal screening revealed abnormal results, Dr. Sara Teichholtz turned to MSK. Her care team diagnosed her with a rare cancer and developed a treatment plan. Nearly three years later, she has no evidence of disease.
about 1 month ago
1
1
0
MSK researchers found that locoregional recurrence (LRR) rates were significantly lower for
#breastcancer
patients who completed at least one form of adjuvant therapy after
#lumpectomy
.
loading . . .
Tailoring Adjuvant Therapy for Younger Patients with Low-Risk Breast Cancer
When considering adjuvant therapy preferences for younger patients ages 50 to 69 with early-stage, low genomic risk breast cancer, is it reasonable to omit radiotherapy or endocrine therapy after lump...
https://www.mskcc.org/clinical-updates/tailoring-adjuvant-therapy-for-younger-patients-with-low-risk-breast?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+Dr.+Braunstein&utm_campaign=Social+Media+Posts+October+2025
about 1 month ago
0
1
2
reposted by
Memorial Sloan Kettering Cancer Center
Benjamin D. Greenbaum
about 1 month ago
Thank you
@mskcancercenter.bsky.social
for highlighting our work on
#viralmimicry
in our genome, its evolution, the selective forces on it, and its potential role in cancer. A great years long collaborative effort with
@petrsulc.bsky.social
,
@daniel-decarvalho.bsky.social
, & many great colleagues!
add a skeleton here at some point
1
13
3
MSK computer scientists and radiation oncologists have developed
#AI
models to make
#radiation
therapy safer and more effective — helping to spare healthy tissue and make decisions about needed changes to treatment faster. Learn more:
bit.ly/3KE8tcl
loading . . .
How MSK Doctors Are Using AI To Improve Radiation Treatment
MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the ...
https://www.mskcc.org/news/how-msk-doctors-are-improving-radiation-treatments-with-ai?utm_source=Bluesky&utm_medium=Organic+Social+&utm_term=&utm_content=Image+of+Dr.+Veeraraghavan&utm_campaign=Social+Media+Posts+October+2025
about 1 month ago
0
2
0
Dr.
@bengrbm.bsky.social
has tried to shed light on the innate immune system and how it affects cancer cells as they evolve. Now Dr. Greenbaum’s lab has been taking a deep dive into modeling viral mimicry, trying to understand how this could shape cancer cells’ development process.
bit.ly/3VWadA8
about 1 month ago
0
4
1
Congratulations to MSK's most recent Awards & Appointments honorees, including Dr. Maria Jasin for being awarded the 2025 Peral Meister Greengard Prize, MSK being named one of the World’s Best Specialized Hospitals by
@newsweek.com
, and more ⬇️
loading . . .
MSK Awards and Appointments September 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Maria Jasin Awarded the 2025 Peral Meister Greengard Prize
https://www.mskcc.org/news-releases/msk-awards-and-appointments-september-2025?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+lab+coat&utm_campaign=Social+Media+Posts+October+2025
about 1 month ago
0
0
0
reposted by
Memorial Sloan Kettering Cancer Center
Darcy Burbage, DNP, RN, AOCN
about 1 month ago
What a fantastic day of learning courtesy of
@mskcme.bsky.social
@mskcancercenter.bsky.social
! Can’t wait for tomorrow’s sessions! Thank you
@billyrosaphd.bsky.social
& your planning team 🎉!
1
5
2
New from MSK: A team co-led by Dr. Talya Salz and Dr. Thomas Atkinson are studying how an algorithm guided by a large language model could help identify themes related to the experience of
#cancer
pain from narrative reports. Learn more:
www.mskcc.org/news/msk-res...
about 1 month ago
0
0
0
reposted by
Memorial Sloan Kettering Cancer Center
Asier Antoñana
about 1 month ago
Big news! 🚀 I’m joining MSK as a Postdoctoral Fellow in the Balachandran Lab! 🔬I’ll focus on tumor immunology in pancreatic cancer—harnessing the immune system to advance future therapies. Looking forward to growing with MSK’s research community!
@mskcancercenter.bsky.social
0
5
1
reposted by
Memorial Sloan Kettering Cancer Center
Urvi Shah, MD, MS
about 1 month ago
Krisstina Gowin and I discuss the importance of patient-centered wellness interventions in the field of hematology
@ashclinicalnews.bsky.social
@ash.hematology.org
@mskcancercenter.bsky.social
@cityofhope.bsky.social
ashpublications.org/ashclinicaln...
#mmsm
#lymsm
#bmtsm
#leusm
loading . . .
Bridging the Gap: How Hematology Can Better Support Patient Wellness | ASH Clinical News | American Society of Hematology
https://ashpublications.org/ashclinicalnews/news/8707/Bridging-the-Gap-How-Hematology-Can-Better-Support
0
4
1
MSK's Dr. Nancy Lee presented updated results at the Annual Meeting of
@astro-org.bsky.social
confirming that the addition of pembrolizumab to standard of care improved event-free survival for people with locally advanced
#HNSCC
.
bit.ly/48LfqlI
loading . . .
Pembrolizumab for Locally Advanced Head and Neck Squamous Cell Carcinoma Approved by the FDA for Use Before and After Surgery
Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.
https://bit.ly/48LfqlI
about 1 month ago
0
1
0
At this year's
@astro-org.bsky.social
conference, MSK experts shared their work in more than 60 presentations & poster sessions. The presentations included two clinical trials that looked at the benefits & effects of lowering
#radiation
doses. Check out more highlights from the
#ASTRO25
conference:
loading . . .
ASTRO 2025 Highlights From MSK
Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.
https://www.mskcc.org/news/astro-2025-highlights-from-msk?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+rad+oncs&utm_campaign=Social+Media+Posts+October+2025
about 1 month ago
0
2
0
(1/2) Presented at
#ASTRO25
: Results from a MSK-led clinical trial show that
#protonbeam
radiotherapy resulted in similar oncologic outcomes w/ less toxicity and improved quality of life than
#photonbeam
radiotherapy (intensity modulated
#radiotherapy
, IMRT) in patients w/ head and neck cancers.
about 1 month ago
1
0
0
Coming up at
#ASTRO25
: MSK’s Dr. Nancy Lee will discuss
#neoadjuvant
and
#adjuvant
pembrolizumab plus standard of care in resectable locally advanced head and neck squamous cell
#carcinoma
.
@astro-org.bsky.social
Tuesday, 9/30 | 2:30 p.m. PDT Learn more:
bit.ly/4pNSt7K
about 1 month ago
0
1
0
reposted by
Memorial Sloan Kettering Cancer Center
Stand Up To Cancer
about 2 months ago
Cancer research saves lives. Dan Tukey is a survivor today thanks to the treatment he received in a colorectal cancer clinical trial funded by
#StandUpToCancer
. Help push cancer research further at
StandUpToCancer.org
. ❤️
@mskcancercenter.bsky.social
loading . . .
0
3
1
reposted by
Memorial Sloan Kettering Cancer Center
Linda B. Rosenthal
about 2 months ago
Undergoing chemotherapy doesn’t mean you have to lose your hair or identity. Honored to celebrate the passage of my first-in-the-nation law with Senator Stavisky requiring insurance carriers to cover the cost of scalp cooling at
@mskcancercenter.bsky.social
. 🎉
0
2
1
reposted by
Memorial Sloan Kettering Cancer Center
MSKEducation
about 2 months ago
To all
#MSKPostdocs
- THANK YOU! Your contributions are vital to the
@mskcancercenter.bsky.social
research community. We are proud to celebrate you during
#NPAW2025
and every day of the year! 👏🧪💙
0
6
1
MSK Kids, the pediatric cancer program at MSK, has one of the nation’s largest teams dedicated to neuroblastoma and treats more children w/ this cancer than any other center in the U.S. Learn more about the latest clinical & molecular research advances for patients w/ high-risk
#neuroblastoma
.
loading . . .
MSK Kids: Recent Research Advances for High-Risk Neuroblastoma
MSK Kids is continuously investigating new ways to improve outcomes and the quality of life for pediatric patients with high-risk neuroblastoma. In this article we detail highlights of the latest clin...
https://www.mskcc.org/clinical-updates/msk-kids-recent-research-advances-for-high-risk-neuroblastoma?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Graphic&utm_campaign=Social+Media+Posts+September+2025
about 1 month ago
0
0
1
reposted by
Memorial Sloan Kettering Cancer Center
Fumiko Ladd Chino, MD FASCO
about 2 months ago
Rockstar
#radonc
@mskcancercenter.bsky.social
resident Dr Kaitlyn Lapen presents at
#ASTRO25
on quality of life improvements with early radiation for asymptomatic bone metastasis which may appear after 6 months. Optimal patient selection is key.
@astro-org.bsky.social
0
6
3
Up next at
#ASTRO25
: MSK’s Dr. Alexander Goglia will discuss the impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Follow along for coverage of the latest advances. Monday, 9/29 | 10:45 a.m. PDT Learn more:
bit.ly/483tNla
about 2 months ago
0
3
0
Up next at
#ASTRO25
: MSK’s Dr. Alexander Goglia will discuss the impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Follow along for coverage of the latest advances. Monday, 9/29 | 10:45 a.m. PDT Learn more:
bit.ly/483tNla
about 2 months ago
0
2
0
Up next at
#ASTRO25
: MSK’s Dr. Alok Deshane will discuss TP53 mutations and outcomes after
#radiotherapy
in mantle cell
#ymphoma
. Follow along for coverage of the latest advances. Monday, 9/29 | 10:45 a.m. PDT Learn more:
bit.ly/3W8iq43
about 2 months ago
0
1
0
Radiation therapy for prostate cancer is more precise, convenient, and personalized than ever before. From
#SBRT
to MRI-guided and adaptive approaches, MSK experts are leading advances that improve outcomes and protect quality of life for patients with
#prostatecancer
. ⬇️
loading . . .
The Latest Radiation Therapy for Prostate Cancer: What Every Man Should Know
It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.
https://www.mskcc.org/news/what-every-man-should-know-about-radiation-therapy-prostate-cancer?utm_source=Bluesky&utm_medium=Organic+Social&utm_term=&utm_content=Image+of+rad+onc+and+patient&utm_campaign=Social+Media+Posts+September+2025
about 2 months ago
0
3
3
Cancer research means bigger breakthroughs, on a faster timeline, that improve the lives of people impacted by cancer. Today is World Cancer Research Day & all donations will be DOUBLED. Donate today & help bring more possibilities to families facing cancer.
bit.ly/46mefYy
#WorldCancerResearchDay
about 2 months ago
0
5
1
reposted by
Memorial Sloan Kettering Cancer Center
Journal of Cell Biology
about 2 months ago
ATG16L strikes again! New findings link
#lysosome
stress and physiology. Alison Klein and Michael Overholtzer
@mskcancercenter.bsky.social
discuss new study from
@thabataduque.bsky.social
et al. of the Deretic group (
rupress.org/jcb/article/...
) in Spotlight:
rupress.org/jcb/article/...
0
5
4
reposted by
Memorial Sloan Kettering Cancer Center
VJHemOnc
about 2 months ago
🎥 At
#SOHO2025
, Ariela Noy of
@mskcancercenter.bsky.social
shared insights into the management of Burkitt
#lymphoma
, highlighting the need to improve frontline treatment. Watch here: 👉
buff.ly/kp1MrVH
👈
#LYMsm
#Lymphoma
#HemOnc
#BloodSky
#HemeSky
#MedSky
@societyofhemonc.bsky.social
0
2
3
Join us for MSK's 2025 Health Equity in Cancer Care Conference on Friday, November 14. This complimentary one-day event will unite experts from across fields, institutions, and specialties to explore actionable strategies for advancing
#healthequity
in underserved populations.
about 2 months ago
1
4
1
reposted by
Memorial Sloan Kettering Cancer Center
MSK Department of Medicine
about 2 months ago
Coming up at
#IMS25
: Join MSK's Myeloma Service Chief
@szusmani.bsky.social
to learn about current challenges in
#multiplemyeloma
relapse & future research needed to overcome them.
#mmsm
🗓️ Friday, September 19 | 9:40 a.m. EDT
@mskcancercenter.bsky.social
@myeloma-society.bsky.social
0
5
3
Load more
feeds!
log in